Ameriprise’s Akebia Therapeutics AKBA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$644K Buy
176,948
+164,896
+1,368% +$600K ﹤0.01% 3410
2025
Q1
$23.1K Buy
12,052
+86
+0.7% +$165 ﹤0.01% 3942
2024
Q4
$22.7K Buy
+11,966
New +$22.7K ﹤0.01% 4015
2023
Q1
Sell
-163,400
Closed -$95K 3932
2022
Q4
$95K Sell
163,400
-1,435
-0.9% -$834 ﹤0.01% 3811
2022
Q3
$52K Buy
164,835
+153,637
+1,372% +$48.5K ﹤0.01% 3886
2022
Q2
$4K Buy
+11,198
New +$4K ﹤0.01% 3873
2022
Q1
Sell
-10,549
Closed -$24K 3928
2021
Q4
$24K Sell
10,549
-4,748
-31% -$10.8K ﹤0.01% 3918
2021
Q3
$44K Sell
15,297
-39,580
-72% -$114K ﹤0.01% 3818
2021
Q2
$208K Buy
54,877
+34,380
+168% +$130K ﹤0.01% 3737
2021
Q1
$69K Buy
20,497
+3,018
+17% +$10.2K ﹤0.01% 3789
2020
Q4
$49K Buy
17,479
+421
+2% +$1.18K ﹤0.01% 3719
2020
Q3
$43K Sell
17,058
-116,707
-87% -$294K ﹤0.01% 3680
2020
Q2
$1.82M Buy
133,765
+94,829
+244% +$1.29M ﹤0.01% 2658
2020
Q1
$295K Buy
38,936
+1,260
+3% +$9.55K ﹤0.01% 3307
2019
Q4
$238K Buy
37,676
+2,875
+8% +$18.2K ﹤0.01% 3531
2019
Q3
$133K Buy
34,801
+5,845
+20% +$22.3K ﹤0.01% 3604
2019
Q2
$140K Sell
28,956
-35,400
-55% -$171K ﹤0.01% 3616
2019
Q1
$527K Sell
64,356
-143,734
-69% -$1.18M ﹤0.01% 3267
2018
Q4
$1.15M Buy
208,090
+171,766
+473% +$950K ﹤0.01% 2885
2018
Q3
$321K Buy
36,324
+16,740
+85% +$148K ﹤0.01% 3420
2018
Q2
$196K Sell
19,584
-66,995
-77% -$670K ﹤0.01% 3483
2018
Q1
$825K Sell
86,579
-81,627
-49% -$778K ﹤0.01% 3046
2017
Q4
$2.5M Buy
168,206
+11,706
+7% +$174K ﹤0.01% 2551
2017
Q3
$3.08M Buy
156,500
+71,845
+85% +$1.41M ﹤0.01% 2392
2017
Q2
$1.22M Buy
+84,655
New +$1.22M ﹤0.01% 2855
2016
Q1
Sell
-186,524
Closed -$2.41M 3731
2015
Q4
$2.41M Buy
186,524
+13,190
+8% +$170K ﹤0.01% 2487
2015
Q3
$1.67M Buy
+173,334
New +$1.67M ﹤0.01% 2700